查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1598449

組織消融市場：按類型、技術、適應症分類 - 2025-2030 年全球預測

Tissue Ablation Market by Type (Minimally Invasive Surgery, Open Surgery), Technology (Cryoablation, Electrical Ablation, Hydromechanical Ablation), Indication - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年組織消融市場估值為194.1億美元，預計到2024年將達到208.7億美元，複合年成長率為7.64%，到2030年將達到325億美元。

組織消融是一種醫療程序，涉及去除或破壞異常或不必要的組織，通常使用射頻、雷射、微波或超音波等能量類型。該技術由於其微創方法可減少恢復時間和手術風險，因此在腫瘤學、心臟病學和皮膚病學等多個領域具有重要意義。組織消融的應用範圍包括治療癌性腫瘤、心律不整和子宮肌瘤等良性腫瘤。最終用途包括提供先進醫療護理並需要先進消融技術的醫院、診所和專科手術中心。

主要市場統計
基準年[2023] 194.1億美元
預測年份 [2024] 208.7億美元
預測年份 [2030] 325億美元
複合年成長率（%） 7.64%

全球組織消融市場受到多種成長要素的影響，包括提高精度和有效性的技術進步、尋求創新治療方法的慢性疾病數量的增加以及微創手術的成長趨勢。此外，世界人口老化對符合調查方法的治療方法提出了巨大的潛在需求。機會在於擴大適應症和改進現有技術，從而增加其在各種醫療程序中的使用。透過利用人工智慧和機器學習，公司可以提高手術成功率和患者治療效果。

然而，市場受到一些挑戰的限制，例如先進消融系統的高成本、缺乏執行這些手術的熟練專業人員以及減緩產品核可流程的嚴格法規環境。此外，新興國家也面臨醫療基礎設施不足等障礙。

研究和開發的創新領域包括開發可攜式、經濟高效的消融設備、生物靶向消融技術以及結合診斷和消融功能以實現更個性化治療的整合平台。市場動態是動態的，其特點是快速的技術創新和持續的研究。尋求發展的公司專注於與醫療保健提供者合作，以展示價值和有效性，投資於研究和開發以持續改進消融設備，並利用其相對於傳統方法的優勢。。

市場動態：揭示快速發展的組織消融市場的關鍵市場洞察

供需的動態交互作用正在改變組織消融市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 慢性病和人口老化的流行
    • 技術進步和 MI 程序的增加
    • 越來越多在腫瘤手術中使用醫用雷射
  • 市場限制因素
    • 嚴格規定
  • 市場機會
    • 機器人導航技術的發展
    • 輕鬆獲得先進的雷射消熔治療
  • 市場挑戰
    • 缺乏熟練的專業人員

波特五力：駕馭組織消融市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解組織消融市場的外部影響

外部宏觀環境因素在塑造組織消融市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解組織消融市場的競爭狀況

組織消融市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣組織消融市場供應商績效評估

FPNV定位矩陣是評估組織消融市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

制定組織消融市場成功之路的策略分析與建議

組織消融市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病盛行率和老年人口
      • 技術進步和 MI 程序的增加
      • 越來越多在腫瘤手術中使用醫用雷射
    • 抑制因素
      • 嚴格監管之路
    • 機會
      • 機器人導航技術的發展
      • 獲得先進的雷射消熔治療
    • 任務
      • 缺乏熟練的專業人員
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章組織消融市場：依類型

  • 微創手術
  • 開放性手術

第7章組織消融市場：依技術分類

  • 冷凍療法
  • 電消融
  • 流體機械消融
  • 光/雷射消熔
  • 微波消融
  • 射頻消融術
  • 超音波消融

第8章組織消融市場（按適應症）

  • 心臟病學
  • 美麗
  • 婦科
  • 腫瘤學
  • 眼科
  • 泌尿系統

第9章美洲組織消融市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太組織消融市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲組織消融市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Alcon Inc.
  • Angiodynamics, Inc.
  • Atricure, Inc.
  • Biosense Webster Inc.
  • Boston Scientific Corporation
  • CR Bard Inc.
  • Ethicon, Inc.
  • Galil Medical, Inc.
  • HealthTronics, Inc.
  • HS Hospital Service SPA
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC
  • Misonix, Inc.
  • NeuWave Medical, Inc.
  • Olympus Corporation
  • Smith & Nephew Plc
  • SonaCare Medical LLC
  • Stryker Corporation
Product Code: MRR-03100B7643D6

The Tissue Ablation Market was valued at USD 19.41 billion in 2023, expected to reach USD 20.87 billion in 2024, and is projected to grow at a CAGR of 7.64%, to USD 32.50 billion by 2030.

Tissue ablation is a medical procedure that involves the removal or destruction of abnormal or unwanted tissue, often utilizing energy types such as radiofrequency, laser, microwave, or ultrasound. This technique is crucial in various fields, including oncology, cardiology, and dermatology, owing to its minimally invasive approach which reduces recovery time and surgical risks. Applications of tissue ablation span across treatments for cancer tumors, cardiac arrhythmias, and benign growths like fibroids. The end-use scope includes hospitals, clinics, and specialized surgical centers that provide such advanced medical care and require sophisticated ablation technologies.

KEY MARKET STATISTICS
Base Year [2023] USD 19.41 billion
Estimated Year [2024] USD 20.87 billion
Forecast Year [2030] USD 32.50 billion
CAGR (%) 7.64%

The global market for tissue ablation is influenced by several growth factors, including technological advancements that enhance precision and efficacy, an increasing prevalence of chronic diseases that demand innovative treatment options, and a growing trend toward minimally invasive surgeries. Moreover, the aging global population presents a vast potential demand for treatments consistent with tissue ablation methodologies. Opportunities lie in expanding indications and improving existing technologies, thereby increasing their use in diverse medical procedures. Companies could leverage artificial intelligence and machine learning to enhance procedural success rates and patient outcomes.

However, the market is constrained by challenges such as high costs of advanced ablation systems, a lack of skilled professionals capable of performing these procedures, and stringent regulatory environments that slow product approval processes. Additionally, emerging economies face barriers like inadequate healthcare infrastructure.

Innovative areas ripe for research include the development of portable and cost-effective ablation devices, bio-targeted ablation techniques, and integrated platforms that combine diagnostic and ablation capabilities for more personalized treatments. The tissue ablation market is dynamic, characterized by rapid technological change and ongoing research. Companies aiming for growth should focus on partnerships with healthcare providers to demonstrate value and efficacy, invest in R&D for the continual improvement of ablation devices, and educate stakeholders on advantages over traditional methods to drive adoption.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Tissue Ablation Market

The Tissue Ablation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of chronic diseases and geriatric population
    • Technology advancements and increase in MI procedures
    • Increased use of medical lasers for oncology procedures
  • Market Restraints
    • Stringent regulatory path
  • Market Opportunities
    • Development in robotic navigation technologies
    • Accessibility to advanced laser ablation treatments
  • Market Challenges
    • Dearth of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Tissue Ablation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Tissue Ablation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Tissue Ablation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Tissue Ablation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Tissue Ablation Market

A detailed market share analysis in the Tissue Ablation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Tissue Ablation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Tissue Ablation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Tissue Ablation Market

A strategic analysis of the Tissue Ablation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Tissue Ablation Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alcon Inc., Angiodynamics, Inc., Atricure, Inc., Biosense Webster Inc., Boston Scientific Corporation, C.R Bard Inc., Ethicon, Inc., Galil Medical, Inc., HealthTronics, Inc., HS Hospital Service S.P.A, Johnson & Johnson Services, Inc., Medtronic PLC, Misonix, Inc., NeuWave Medical, Inc., Olympus Corporation, Smith & Nephew Plc, SonaCare Medical LLC, and Stryker Corporation.

Market Segmentation & Coverage

This research report categorizes the Tissue Ablation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Minimally Invasive Surgery and Open Surgery.
  • Based on Technology, market is studied across Cryoablation, Electrical Ablation, Hydromechanical Ablation, Light/Laser Ablation, Microwave Ablation, Radiofrequency Ablation, and Ultrasound Ablation.
  • Based on Indication, market is studied across Cardiology, Cosmetology, Gynecology, Oncology, Ophthalmology, and Urology.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic diseases and geriatric population
      • 5.1.1.2. Technology advancements and increase in MI procedures
      • 5.1.1.3. Increased use of medical lasers for oncology procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory path
    • 5.1.3. Opportunities
      • 5.1.3.1. Development in robotic navigation technologies
      • 5.1.3.2. Accessibility to advanced laser ablation treatments
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Tissue Ablation Market, by Type

  • 6.1. Introduction
  • 6.2. Minimally Invasive Surgery
  • 6.3. Open Surgery

7. Tissue Ablation Market, by Technology

  • 7.1. Introduction
  • 7.2. Cryoablation
  • 7.3. Electrical Ablation
  • 7.4. Hydromechanical Ablation
  • 7.5. Light/Laser Ablation
  • 7.6. Microwave Ablation
  • 7.7. Radiofrequency Ablation
  • 7.8. Ultrasound Ablation

8. Tissue Ablation Market, by Indication

  • 8.1. Introduction
  • 8.2. Cardiology
  • 8.3. Cosmetology
  • 8.4. Gynecology
  • 8.5. Oncology
  • 8.6. Ophthalmology
  • 8.7. Urology

9. Americas Tissue Ablation Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Tissue Ablation Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Tissue Ablation Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Alcon Inc.
  • 3. Angiodynamics, Inc.
  • 4. Atricure, Inc.
  • 5. Biosense Webster Inc.
  • 6. Boston Scientific Corporation
  • 7. C.R Bard Inc.
  • 8. Ethicon, Inc.
  • 9. Galil Medical, Inc.
  • 10. HealthTronics, Inc.
  • 11. HS Hospital Service S.P.A
  • 12. Johnson & Johnson Services, Inc.
  • 13. Medtronic PLC
  • 14. Misonix, Inc.
  • 15. NeuWave Medical, Inc.
  • 16. Olympus Corporation
  • 17. Smith & Nephew Plc
  • 18. SonaCare Medical LLC
  • 19. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. TISSUE ABLATION MARKET RESEARCH PROCESS
  • FIGURE 2. TISSUE ABLATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TISSUE ABLATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TISSUE ABLATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TISSUE ABLATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TISSUE ABLATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TISSUE ABLATION MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TISSUE ABLATION MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES TISSUE ABLATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES TISSUE ABLATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. TISSUE ABLATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. TISSUE ABLATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TISSUE ABLATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TISSUE ABLATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TISSUE ABLATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TISSUE ABLATION MARKET DYNAMICS
  • TABLE 7. GLOBAL TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TISSUE ABLATION MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TISSUE ABLATION MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TISSUE ABLATION MARKET SIZE, BY CRYOABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TISSUE ABLATION MARKET SIZE, BY ELECTRICAL ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TISSUE ABLATION MARKET SIZE, BY HYDROMECHANICAL ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TISSUE ABLATION MARKET SIZE, BY LIGHT/LASER ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TISSUE ABLATION MARKET SIZE, BY MICROWAVE ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TISSUE ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TISSUE ABLATION MARKET SIZE, BY ULTRASOUND ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL TISSUE ABLATION MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL TISSUE ABLATION MARKET SIZE, BY COSMETOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL TISSUE ABLATION MARKET SIZE, BY GYNECOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL TISSUE ABLATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL TISSUE ABLATION MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL TISSUE ABLATION MARKET SIZE, BY UROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES TISSUE ABLATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. MALAYSIA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. PHILIPPINES TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. SINGAPORE TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. SOUTH KOREA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. TAIWAN TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. THAILAND TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. VIETNAM TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. DENMARK TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. EGYPT TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. FINLAND TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. FRANCE TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. GERMANY TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. ISRAEL TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. ITALY TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. NETHERLANDS TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. NIGERIA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. NORWAY TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. POLAND TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. QATAR TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. RUSSIA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. SAUDI ARABIA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH AFRICA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. SPAIN TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. SWEDEN TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. SWITZERLAND TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. TURKEY TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED ARAB EMIRATES TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 152. TISSUE ABLATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 153. TISSUE ABLATION MARKET, FPNV POSITIONING MATRIX, 2023